Abstract
Background and Aims : Diabetes Mellitus (DM) is a metabolic disorder affecting ten percent of the worldwide population. The morbidity of DM patients is strongly correlated to cardiovascular diseases (CVD), including cerebrovascular disease, peripheral vascular conditions, and ischemic heart disease. Previous studies have shown that vascular smooth muscle cells (VSMC) from DM patients are often functionally impaired with increased expressions of inflammatory and pro-fibrotic genes. Given its importance in arteriopathy, we aim to understand better the molecular pathway leading to VSMC phenotype modulation in DM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
